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The classical view of the Th1/Th2 paradigm posits that the pathogen nature, infectious
cycle, and persistence represent key parameters controlling the choice of effector mecha-
nisms operating during an immune response. Thus, efficient Th1 responses are triggered
by replicating intracellular pathogens, while Th2 responses would control helminth infec-
tion and promote tissue repair during the resolution phase of an infectious event. However,
this vision does not account for a growing body of data describing how pathogens exploit
the polarization of the host immune response to their own benefit. Recently, the study of
macrophages has illustrated a novel aspect of this arm race between pathogens and the
immune system, and the central role of macrophages in homeostasis, repair and defense
of all tissues is now fully appreciated. Like T lymphocytes, macrophages differentiate into
distinct effectors including classically (M1) and alternatively (M2) activated macrophages.
Interestingly, in addition to represent immune effectors, M1/M2 cells have been shown to
represent potential reservoir cells to a wide range of intracellular pathogens. Subversion
of macrophage cell metabolism by microbes appears as a recently uncovered immune
escape strategy. Upon infection, several microbial agents have been shown to activate host
metabolic pathways leading to the production of nutrients necessary to their long-term per-
sistence in host. The purpose of this review is to summarize and discuss the strategies
employed by pathogens to manipulate macrophage differentiation, and in particular their
basic cell metabolism, to favor their own growth while avoiding immune control.
Keywords: macrophage polarization, metabolic switch, amino acid metabolism, hypoxia, iron, PPARs, infection,
immune escape strategy
TH1/TH2 PARADIGM AND INFECTIOUS IMMUNOLOGY
Historically , immunology emerged as an independent scientific
discipline whose aim was to understand and possibly ameliorate
the development of vaccines, a medical practice that was mostly
pioneered, in an empirical fashion, by microbiologists of the end
of the 19th century. Notably, however, the establishment of funda-
mental immunological concepts and paradigms, such as B and T
cell collaboration or tolerance, was based on a reductionist (or ana-
lytical) approach that departed from a classical “host-pathogen”
view of immunology, by putting much emphasis on self/non-self
discrimination concepts explored with simpler protein antigens
such as ovalbumin or keyhole limpet hemocyanin (KLH).
The discovery that CD4+ T cells can be characterized by dis-
tinct “cytokine signatures” by Mosmann and Coffman in 1986
(1) marked the great return of infection in immunology, lead-
ing to emergence of the Th1/Th2 “division of labor” paradigm
in 1989, and its application to the field of vaccinology since the
early 1990s. This concept led to a critical appraisal of the multi-
ple and diverse sets of immune effectors promoting the now well
established idea that the best immune response is often not the
most intense nor the most specific but rather the best adapted to
counteract or control the pathogen infectious cycle in the host. In
consequence, identification of the nature of pathogens, selection
of the appropriate immune response, repression of damaging or
inadequate immune response are now recognized as crucial steps
for the successful control of an infectious event. Thus, the immune
reaction must be adapted to eliminate or control the pathogen
and to restore homeostatic conditions during an infection to pre-
vent severe tissue damage (2); for review see Ref. (3). The high
frequency of chronic infections observed in nature demonstrates
that pathogens are, however, able to manipulate these responses to
evade immune control or even subvert immune reactions to their
own advantage.
This review highlights current understanding of the interplay
between pathogens and macrophages with a special emphasis on
the role of metabolism regulation in the control of infections
in mouse models unless otherwise stated. A clear understanding
of the importance of macrophage polarization may reveal novel
strategies for controlling infectious diseases.
CLASSICALLY AND ALTERNATIVELY ACTIVATED
MACROPHAGE
Myelomonocytic cells are an essential component of innate immu-
nity and represent the first line of defense against pathogens.
Myelomonocytic cells fulfill a variety of homeostatic functions,
which go beyond host defense and include tissue remodel-
ing during embryogenesis, wound healing (fibrin dissolution,
removal of dead tissues, fibroblast recruitment and growth and
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connective-tissue remodeling), as well as orchestration and contri-
bution to metabolic activity [reviewed in Ref. (4–6)]. Myelomono-
cytic cell function needs to be tailored to their tissue of residence,
an adaptation that is driven by tissue-derived factors and by the
physiological environment.
The myelomonocytic cell populations are particularly dynamic
during inflammation or infection. Under such conditions, blood
monocytes are recruited into the tissues, where they differentiate
into macrophages or dendritic cells. Depending on the microen-
vironment, macrophages can acquire distinct functional pheno-
types. The concept of macrophage polarization was first defined
in 1992 with the discovery that IL-4 inhibits the respiratory burst
of macrophages while enhancing expression of MHC-II and man-
nose receptors (CD206) on their cell surface (7). Since then, two
opposite and competing phenotypes, often referred to as classically
activated macrophages (M1 macrophages) and alternatively acti-
vated macrophages (M2 macrophages) [reviewed in Ref. (8–10)]
have been defined and identified in several physiological settings.
The M1/M2 nomenclature is derived from the Th1 and Th2
cytokines that are associated with these macrophage phenotypes.
M1 macrophages differentiate under the influence of IFN-γ
and/or LPS and display functional subdivisions depending on
stimulation (11). They are usually characterized by increased
microbicidal activity, as witnessed by the secretion of high levels of
pro-inflammatory cytokines such as TNFα and IL-6, production
of reactive oxygen intermediates (ROI) and nitric oxide synthase-2
(NOS-2/iNOS)-dependent reactive nitrogen intermediates (RNI);
high antigen-presenting activity and increased production of IL-
12. These characteristics are promoted by IFN-γ-mediated Janus
kinase–signal transducer and activator of transcription (JAK–
STAT) signaling or directly by pathogen associated molecular
patterns (PAMPs) such as LPS. M1 macrophages constitute the
first line of defense against intracellular pathogens and promote
or amplify Th1 polarization of CD4+ lymphocytes by IL-12
production.
M2 macrophages have been initially identified in the context of
infection by helminths, differentiating from monocytic precursors
under the influence of IL-4 and IL-13 produced during a strongly
Th2-polarized response. M2-like cells have been described in dif-
ferent pathological conditions such as infections by intracellular
bacteria or virus, allergy, diabetes, and cancer [reviewed in Ref. (8,
9, 12)]. They are characterized by the selective expression of mark-
ers such as arginase 1 (Arg1), chitinase-like protein (for example,
Ym1), Fizz1 (Found in Inflammatory Zone 1), CD36 (fatty acid
translocase), and CD206, as well as the production of low lev-
els of IL-12 and iNOS. Depending on the context, differences in
the expression of M2-associated phenotypic markers have been
recognized, leading to a redefinition of this cell population to
accommodate a diverse set of subtypes: M2a (induced by expo-
sure to IL-4 or IL-13) and M2b [induced by stimulation with
immune complexes, TLR, or the IL-1 receptor antagonist (IL-1ra)]
macrophages drive Th2 responses, whereas M2c cells (generated
by stimulation with IL-10) play a predominant role in the sup-
pression of immune responses and tissue remodeling [reviewed in
Ref. (13)].
In addition, M1 and M2 macrophages differentially express
a panel of co-stimulatory receptors of the B7 family. M1
macrophages have been shown to express higher levels of CD86
and PD-L1, whereas M2 macrophages display elevated levels of
PD-L2. The expression differences are less clear for CD80 (14, 15).
It should be noted that macrophages with intermediate or over-
lapping phenotypes have been observed in vivo. For example,
adipose tissue macrophages from obese mice have a mixed profile,
with upregulation of several M1 and M2 gene transcripts (16).
Taken together, these observations suggest that the prototypical
M1 and M2 phenotypes probably represent extremes of a contin-
uum spectrum of functionally distinct cell types. In this review, we
will focus mainly on the role of M1 and M2a macrophages, these
latter identified on the basis of high Arg1 expression and STAT6
pathways dependence.
MACROPHAGE POLARIZATION IS ASSOCIATED TO A SHIFT
OF METABOLIC PROGRAM
M1 and M2 macrophages display a drastic shift in the amino acid,
glucose, lipid, and iron metabolism [reviewed in Ref. (6, 17)]. We
discuss several aspects of metabolic shift in relation to pathogen
growth control.
AMINO ACID METABOLIC SHIFT
Amino acid catabolism represents a key mechanism whereby
M1 and M2-types macrophages exert their anti-microbial and
immunoregulatory roles. Tryptophan and arginine degradation
by innate immune cells represents the most studied examples of
functional links between amino acid metabolism and immune
function. This relationship is quite complex, because selected
degradation of amino acids can not only affect an immune
response through the depletion of important precursors to pro-
tein synthesis, but also generates new catabolites endowed with
immunoregulatory functions. In keeping with the general pur-
pose of this review, we will mostly discuss herein the known
links between expression and function of amino acid catabolizing
enzymes and M1/M2 differentiation.
Among the three different enzymes, indoleamine 2,3-
dioxygenase 1 (IDO1), 2 (IDO2), and tryptophan 2,3-dioxygenase
(TDO), which catalyze oxidative Trp catabolism, IDO1 represents
the best known and widely studied example illustrating how amino
acid metabolism and immune regulation interface. IDO1 has been
shown to confer potent anti-microbial activities in vitro. Through
the depletion of the essential amino acid tryptophan, IDO1 can
restrict in vitro the growth of a wide range of pathogens, including
viruses, bacteria, and protozoa (18–22). Although IDO1 is consti-
tutively expressed by numerous tissues including the epididymis,
uterus, spleen, small intestines, and prostate (23), its expression is
highly inducible by both type I and type II interferons, with IFN-γ
considered as one of the strongest inducers of IDO expression and
activity. As a consequence, and despite the fact that IDO1 expres-
sion is not restricted to hematopoietic cells, some authors have
come to consider IDO1 as a prototypical M1 marker (11).
The role of IDO1 as potent anti-microbial agent in vivo
remains, however, questionable, due in particular to the well-
known immunosuppressive function of IDO1-expressing cells.
Increased tryptophan catabolism has been indeed observed in
the tumor microenvironment and in the placenta, contributing
to tolerance to, respectively, tumor and fetal antigens. Although
Frontiers in Immunology | T Cell Biology November 2014 | Volume 5 | Article 603 | 2
Muraille et al. Macrophage metabolism in infection
apparently at odds with the anti-microbial properties of IDO1,
recent observations seem to concur with the notion that despite its
association to an M1-like state, IDO1 may indeed primarily medi-
ate anti-inflammatory/regulatory roles in vivo opposing pathogen
clearance. Indeed, genetic IDO1 ablation or pharmacological inhi-
bition of IDO reduced parasitic load in Leishmania major infected
mice (24). Similarly, in vivo administration of a pharmacological
inhibitor of IDO to Toxoplasma gondii infected mice or infection
of an IDO1-deficient mouse strain led to a more efficient control
of parasite growth by IDO1-impaired hosts (25). In keeping with
this prevalent immunoregulatory role of IDO1 in vivo, inhibition
of IDO1 activity enhanced both CD4 and CD8 T cell responses to
influenza virus infection, globally improving the antigen-specific
memory response to this virus (26, 27).
Recent observations, albeit performed exclusively in vitro, have
shed a new light on the possible role of IDO1 in the M1 vs M2 dif-
ferentiation pathways (28). In this study, the authors demonstrate
that forced expression of IDO1 in the human acute monocyte
leukemia cell line THP-1 is sufficient to induce an M2-like pro-
file, characterized by high IL-10 and low IL-12 expression pattern.
Similarly, siRNA-mediated inhibition of IDO1 expression led to
an increased expression of M1 markers, suggesting an important
and cell autonomous role for IDO1 in regulating macrophage
polarization. Collectively, and although the molecular and cellular
mechanisms need to be identified, the available evidence suggests
the existence of negative feedback regulatory loop whereby expres-
sion of IDO1 under M1-polarizing conditions contributes to the
attenuation of a T cell mediated inflammatory response while
favoring a M1 to M2 shift in macrophages.
Elevated arginine catabolism has also been linked to
immunoregulation and anti-microbial immunity. Noteworthy,
two of the prototypic M1 and M2 markers (respectively, iNOS
and Arg1) have the capacity to use l-arginine as a substrate, lead-
ing to the production of l-citrulline and nitric oxide (NO), or
l-ornithine and urea, respectively. The finding that concentrations
of l-arginine at site of inflammation often decline to undetectable
levels suggests an important role for l-arginine catabolism during
an immune response (29, 30).
Products of Arg1 vs iNOS appear to fulfill diametrically
opposed functions (Figure 1). Arg1 enhances collagen synthesis
and cell growth via l-ornithine production, while iNOS opposes
cell viability and proliferation. Moreover, iNOS protein translation
appears as particularly sensitive to l-arginine levels, providing a
further mechanism, in addition to competition for the same sub-
strate, of counter-regulation between these two enzymes (31). This
substrate competition between iNOS and Arg1 has been exten-
sively described in mouse models (32), and further studies may
be required to validate the universality of this concept in other
species. Arginase activity has been found in lesions of patients with
cutaneous leishmaniasis and in human tuberculous granulomas,
suggesting an evolutionary conserved response linking arginine
metabolism to infection (33–35).
M1-derived NO represents a major effector molecule in
macrophage-mediated cytotoxicity, playing an important role in
controlling bacterial and parasitic infections (36–38). In keep-
ing with the previously discussed antagonistic role of Arg1
and iNOS, induction of arginase activity represents an efficient
FIGURE 1 | Schematic representation of l-arginine catabolism in M1
and M2a-type macrophages.
immune escape strategy developed by several pathogens. As an
example, active induction of Arg1 gene transcription in infected
macrophages through manipulation of the STAT6 signaling path-
way has been demonstrated for both T. gondii and Leishmania
donovanii (39–41). The discovery that T cells are particularly
sensitive to local arginine concentrations has further confirmed
the important immunoregulatory role of Arg1, able therefore
to inhibit both innate (NO production) and adaptive immune
responses to parasites (30, 32). In addition to its immunoreg-
ulatory role, increased arginine metabolism has been shown
to directly promote intracellular growth of several Leishmania
species, notably through the accumulation of polyamines (42, 43).
A compelling argument in favor of a role of arginine catabolism
in promoting parasite growth is the expression of endogenous
arginase by several parasites including Leishmania, Crithidia, and
Leptomonas [see Ref. (44) for review].
Most of the available evidence links therefore Arg1 expression,
and thus the M2 phenotype, to a disease-promoting activity. Note-
worthy, however, expression of Arg1 in macrophages also plays an
important role in protecting the host against the lethal effects of
chronic Th2 pathology, as recently demonstrated in mice infected
by Schistosoma mansoni (45). A similar role for Arg1 in suppress-
ing pathologic inflammation has been derived from studies con-
ducted in acutely S. mansoni-infected Arg1-deficient bone marrow
chimeric mice (46). Finally, the importance of Arg1 in wound
healing has been recently demonstrated using both pharmacolog-
ical inhibition of arginase activity and genetic deletion of Arg1 in
both haematopoietic and endothelial cells, further illustrating the
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important and positive role of this enzyme in tissue repair and
homeostasis (47).
Although expression of Arg1 is often associated to an
immunoregulatory/pathogen-growth promoting setting, recent
studies have uncovered a previously unsuspected effector role
for this enzyme against nematode infection. In models of sec-
ondary infections, arginase activity was found to play a key role
in the acquired protective immunity against reinfection with an
intestinal helminth. Upon primary exposure to Nippostrongylus
brasiliensis, mice developed the capacity to retain larvae in the
infected skin, thus reducing the worm burden in the lungs (48). In
this model, Arg1 was shown to play a key role in larvae trapping,
confirming previously suspected antiparasitic effects of arginase
activity against Heligmosomoides polygyrus (49). The capacity of
the arginine catabolite l-ornithine to inhibit H. polygyrus lar-
vae mobility suggests a plausible mechanism whereby Arg1 may
protect the host during parasitic infections (50).
In summary, catabolism of both tryptophan and l-arginine
lays at the heart of the M1/M2 dichotomy. Arginine catabolism
represents an important immune mechanism limiting pathogen
growth and spread, exploited by both M1 (through iNOS) and
M2 (via Arg1) – like macrophages. Through distinct and mutually
exclusive enzymatic reactions, the same amino acid can therefore
be exploited to generate effector molecules tailored to different
pathogens. Moreover, both iNOS and Arg1 have also been shown
to dampen excessive inflammatory and T-cell mediated reactions.
Whether these counter-regulatory properties have been evolution-
ary selected to control unwanted immune activity or represent
unintended side effects remains to be established. In marked con-
trast, it is difficult at present to evaluate the precise role of IDO1
as an anti-microbial effector. Despite a large body of in vitro data,
a role for IDO1 in limiting pathogen growth in vivo is still lacking,
suggesting that despite being associated to an M1-like subpopula-
tion of cells, tryptophan catabolism may primarily serve a regula-
tory role in vivo. In conclusion, amino acid catabolism elegantly
illustrates the dual function of M1 and M2 macrophages, both sub-
sets being able to express anti-microbial and immunoregulatory
functions.
HYPOXIA
Decrease in oxygen pressure (hypoxia) in tissues can result from
various causes such as mechanical or infection induced inflamma-
tion, intense metabolic activity but also obesity and tumor growth
[reviewed in Ref. (51)]. The transcription factor hypoxia-inducible
factor-1 (HIF-1) is a central mediator of hypoxic adaptation. In
normoxia, HIF-1 is repressed primarily through the action of a
family of hydroxylases, which targets HIF-1 subunits for degra-
dation in an oxygen-dependent manner. In hypoxia, HIF-1 is
rapidly stabilized in cells and induces the expression of hundreds
of genes, which regulate angiogenesis, metabolism, growth and
survival (50).
In 1938, Kempner was the first to associate cellular metabo-
lism and inflammation: he examined the chemical composition
of control or inflamed tissues and reported chemical changes that
he interpreted as mainly due to the aerobic glycolysis of blood
cells (52). There is indeed growing evidence that tissue foci of
inflammation display a declining oxygen gradient, as compared
to oxygen-rich blood stream, leading to increased cellular HIF-1α
levels particularly in phagocytes, and activation of genes required
to maintain viability and activity in these demanding conditions
(low oxygen and glucose). It is noteworthy that HIF-1α may also
exert regulatory effects in normoxia, in particular during bacter-
ial infection, where HIF-1α expression is stimulated through TLR
receptor engagement and cell signaling pathways (such as NF-κB
and MAPK) [for review see Ref. (53)].
Exposure of primary human monocyte-derived macrophages
to hypoxia for 16 h has been shown to result in increased mRNA
levels for vascular endothelial growth factor (VEGF), glucose
transporter (GLUT-1), and matrix metalloproteinase 7 (MMP-
7) (54). Induction of VEGF in hypoxic conditions is involved in
the pro-angiogenic activities of macrophages in tumors, whereas
GLUT-1, a glucose transporter, may favor macrophage survival in
ischemic tissues by increasing glucose uptake for glycolytic pro-
duction of energy (Figure 2). The increase in mRNA coding for
MMP-7 could have several consequences, as MMP-7, the small-
est MMP, is able to digest many components of the basement
membrane and extracellular matrix, and is involved in proteolytic
processing, leading to activation of TNF-α, defensins, and other
MMPs.
A number of reports have shown that hypoxia profoundly
affects macrophage recruitment and development of M1 asso-
ciated anti-microbial functions. Specific deletion of HIF-1α in
the myeloid lineage resulted in lower ATP levels caused by
decreased glycolysis. This metabolic defect results in profound
impairment of myeloid cell aggregation, motility, invasiveness,
and bacterial killing (55). Analysis of intracellular killing of
Group B streptococci by bone marrow-derived macrophages
revealed approximately sevenfold more viable bacteria within
the HIF-1α deficient macrophages as compared with the wild-
type cells. In vivo, loss of HIF-1α in myeloid cells impaired
FIGURE 2 | Schematic representation of polarized metabolism in M1
and M2a-type macrophages.
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infiltration at the dermal-epidermal border of inflamed skin and
prevented resolution of passively induced arthritis. HIF-1α ago-
nist mimosine and the pharmacological agent AKB-4924 (which
stabilizes HIF-1) were both shown to enhance the antibacterial
activity of phagocytes and to kill the pathogen Staphylococcus
aureus in vitro and in vivo (56, 57). Conversely, mice lacking
HIF-1α in their myeloid lineage developed larger necrotic skin
lesions upon subcutaneous infection with group A Streptococcus
(58). Murine macrophages exposed to low oxygen tensions have
been shown to display M1 phenotype as suggested by increased
antigen-presenting and phagocytic functions that involved IFN-γ
production (59).
Collectively, these observations indicate that HIF-1α critically
regulates pathways essential for the maintenance of energy home-
ostasis and function of macrophages in sites deprived of oxy-
gen. However, a recent report contradicts this conclusion, as the
authors found that hypoxia in L. major skin lesions impaired
the NO-dependent leishmanicidal activity of macrophages in a
reversible manner. The mechanism was found to involve impaired
translation of NOS protein (60). This latter study is in accor-
dance with two recent reports showing (i) that tumor-infiltrating
macrophages in hypoxic areas displayed an altered pro-tumoral
phenotype, characterized by impaired M1-type function (61) and
(ii) that tumor-derived lactic acid induced vegf and Arg1 and
the M2-like polarization of tumor-associated macrophages in a
HIF-1α-dependent manner (62).
IRON METABOLISM
Iron is an ideal redox catalyst, accepting or donating electrons,
implicated in numerous cellular processes such as respiration,
DNA replication but also host defenses by the production of
reactive oxygen and nitrogen intermediates. Almost all living
organisms from archaea to eukaryotes display absolute require-
ment for iron [reviewed in Ref. (63–65)]. Erythropoiesis is the
most avid consumer of iron in the mammal organism as erythro-
cytes contain approximately 1 billion of ferric atoms. Approxi-
mately 60–70% of the human adult body iron is bound within
hemoglobin ( 2.5 g). Macrophages play a central role in regulat-
ing iron metabolism since they recycle heme iron from senes-
cent erythrocytes and regulate its storage. On the other hand,
microbes have evoked multiple strategies to utilize iron because
a sufficient supply of this metal is linked to pathogen prolifer-
ation, virulence and persistence. The expression of iron uptake
systems is linked to virulence in a broad range of pathogens
including bacteria, protozoa and fungi. The control over iron
homeostasis is thus of central importance in host–pathogen inter-
action, in which both opponents compete for iron. A complex
network of host proteins renders this valuable nutrient largely
inaccessible to pathogens, a concept usually known as “nutri-
tional immunity.” Of course, control of intra- and extracellular
pathogens requires distinct mechanisms of iron restriction in dif-
ferent compartments. M1 macrophages, by repressing ferroportin
(a cellular iron exporter) and CD163 (a hemoglobin scavenger
receptor) and inducing ferritin (which favors iron intracellular
sequestration and storage), reduce the labile iron pool (LIP), the
metabolically active fraction of cytosolic iron that is available
for metabolic purposes. In contrast, through the upregulation of
ferroportin and the downregulation of ferritin, M2 macrophages
have reduced iron storage and enhanced release of iron (66).
Sequestration of iron by M1 macrophages would have a bacte-
riostatic effect (since iron is essential to support bacterial growth)
and thus represents a host protective response. Conversely, iron
release from M2 macrophages would favor tissue repair. Inter-
estingly, iron is also an important regulator of immune effector
functions, immune cell proliferation and cytokine production.
Iron antagonizes the IFN-γ-induced expression of MHC-II, iNOS,
and TNF-α and shifts the Th1/Th2 differentiation toward a Th2
reaction.
LIPID OXIDATIVE METABOLISM
Peroxisome proliferator activated receptors (PPARs) are lipid-
activated transcription factors of the nuclear hormone receptor
superfamily. Endogenous ligands that regulate the PPAR family
remain poorly characterized and include free native and modified
fatty acids. PPARs regulate expression of target genes as obligate
heterodimers with the retinoic X receptors (RXRs). In mammals,
there are three PPAR isoforms (PPARα, -γ, -δ) expressed in a
large variety of cells and playing pleiotropic functions in fatty acid
metabolism including transport, synthesis storage, mobilization,
and oxidation [reviewed in Ref. (67)].
Binding of IL-4 or IL-13 to their cognate receptors, IL-4Rα/IL-
2Rγ and IL-4Rα/IL-13Rα1, respectively, initiates a cytoplasmic
signaling cascade leading to tyrosine phosphorylation of tran-
scription factor STAT6. Phosphorylated STAT6 dimerizes and
translocates to the nucleus, where it induces the expression of
numerous target genes. Among them, PPARγ, PPARδ, and PPARγ-
coactivator-1β (PGC-1β) appear particularly important. PPARγ
mediates the expression of the main M2 phenotype markers such
as Arg1 and CD36 (favoring the uptake of fatty acid and apoptotic
cells) and increases oxidation metabolism of fatty acid [reviewed
in Ref. (68)] (Figure 2). By its transrepressive action, PPARγ
blocks the expression of numerous pro-inflammatory mediators
induced by LPS and IFN-γ such as IL-1β and iNOS. Although
PPARγ is not essential for monocyte/macrophage differentiation,
it functions as an important modulator of macrophage lipid
metabolism and a fine-tuner of immune functions (Figure 3).
Whereas the instructions for alternative macrophage activation are
provided by IL-4 and IL-13, the acquisition and long-term main-
tenance of this phenotype implicate PPARγ and PPARδ. PPARγ
KO mice are deficient in M2 macrophages, develop spontaneous
chronic Th1 inflammation in lung (69) and are more suscepti-
ble to obesity and insulin resistance, suggesting that homeostatic
functions performed by M2 macrophages might allow animals to
more efficiently store and oxidize incoming lipids, thereby main-
taining insulin sensitivity and glucose tolerance by attenuating
inflammation (70).
Reciprocally, fatty acids facilitate the acquisition and mainte-
nance of M2 phenotype (Figure 3). In a PPARδ-dependent man-
ner, monounsaturated fatty acids, such as oleic acid, were found to
synergize with IL-4 to enhance the expression of alternative activa-
tion signature genes such as Arg1 in macrophages. Arg1 promoter
is directly activated by PPAR/RXR heterodimers [reviewed in Ref.
(67)] providing a molecular explanation for the observed synergy
between nutrients and Il-4/IL-13 signaling pathways.
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FIGURE 3 | Interplay between metabolic pathways and M1 and M2a functions.
THE ENERGY SENSORS: AMPK AND mTOR
The AMP-activated kinase (AMPK) represents a well described
energy sensor able to adapt cell metabolism to available substrates
and/or cellular energetic requirements. Accumulation of cellu-
lar AMP, indicative of a reduction in the energy status of the
cell, activates the AMPK, which in turn will phosphorylate a
series of substrates to favor metabolic reactions (such as stim-
ulation of mitochondrial biogenesis, oxidative metabolism and
autophagy), while decreasing ATP consuming, biosynthetic path-
ways. The mammalian target of rapamycin (mTOR) plays a similar
role, by adapting metabolic reactions (such as protein synthe-
sis) to nutrient availability in order to preserve cellular home-
ostasis. Pathogens have been shown to manipulate these regula-
tory pathways to highjack cell metabolism to their own benefit
[reviewed in Ref. (71, 72)]. Collectively, these studies have high-
lighted how, by inhibiting AMPK and/or maintaining an activated
mTOR pathway, pathogens generate essential substrates for their
own replication. Notably, a link between macrophage metabolism
and inflammation has also been recently established. A reduction
in macrophage AMPK activity is associated with M1-like, pro-
inflammatory status, while increased AMPK activity promotes an
anti-inflammatory, M2-type, response [for review see Ref. (73)].
Inhibition of AMPK expression or activity promotes expression
of pro-inflammatory mediators in macrophages activated by LPS
(74). Similarly, AMPKα1 KO macrophages failed to acquire an
M2 phenotype, retaining high levels of iNOS expression even
when stimulated in the presence of M2-polarizing factors such
as IL-4 (75).
In summary, polarization states and functional properties
of macrophages largely depend on environmental conditions,
such as hypoxia, cytokines, pathogen-derived TLR-ligands, and
lipid mediators. Metabolism shift associated to macrophage
polarization appears highly adapted to microbicidal and tissue
regeneration function of M1 and M2 macrophages, respectively.
M2-LIKE POLARIZATION AS A PATHOGEN-INDUCED
IMMUNE ESCAPE STRATEGY
The interaction between pathogenic microbes and their host is
determined by survival strategies to compete for essential nutri-
ents. During evolution, microbes have developed strategies to
access selected nutrients from the host, while these, in return, have
devised defensive means to restrict their availability to pathogens.
Long-term pathogen persistence is frequently the consequence
of a subtle equilibrium between the nutritive needs of host and
pathogens. M2 macrophages appear as a favorable niche for long-
term persistence of numerous intracellular pathogens. Some evi-
dences suggest that intracellular pathogens can induce or benefit
from PPAR expression and/or high iron availability in infected
macrophages.
Mycobacterium tuberculosis, the agent of tuberculosis, is well
adapted to survive within the hostile macrophage environment.
Current evidence (76) indicates that M. tuberculosis and BCG
infection causes a time-dependent upregulation of PPARγ expres-
sion in infected macrophages. Even uptake of dead bacteria trig-
gered PPARγ expression in macrophages, suggesting a pattern
recognition receptor-mediated triggering mechanism. Accord-
ingly, recent studies have shown the implication of TLR2 (77) and
mannose receptor (CD206) (78) in this process. PPARγ expression
and activation led to increased lipid droplet formation, expres-
sion of M2 markers and downmodulation of bactericidal M1
response including respiratory burst and NO production. Involve-
ment of CD36 in lipid droplet formation was further confirmed
by decreased BCG-induced lipid droplet formation in CD36 defi-
cient macrophages (77). These observations suggest that PPARγ
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expression may not only represent an escape mechanism to cir-
cumvent the protective host response, but may also provide the
nutrient rich environment required for mycobacterial growth and
survival by promoting host lipid metabolism.
A key anti-pathogen effector of M1 macrophages is NO, which
is involved in direct killing of pathogens, such as M. tuberculo-
sis. Interestingly, a report has shown that Arg1 was induced in
macrophages in vitro via a STAT6 independent and TLR dependent
pathway, and prevented NO production. The absence of Arg1 was
associated with increased NO expression and enhanced control of
mycobacteria. These observations suggest that chronic infection
could be linked to pathogen-induced Arg1 expression (37). Con-
versely, abrogation of Arg1 expression in hypoxic macrophages
where iNOS was rendered ineffective resulted in exacerbated lung
granuloma pathology and bacterial burden, suggesting that Arg1
could also play a positive role in the control of M. tuberculosis (79).
Iron availability in macrophage is also crucial for Mycobacteria
growth (64, 65). Iron overload enhanced susceptibility while iron-
poor diets reduced Mycobacteria virulence in mice (80). The deple-
tion of intracellular iron occurs in M1 polarized macrophages.
However, Mycobacterium produces siderophores (mycobactins)
with incredible high affinity to iron able to remove iron from trans-
ferrin and lactoferrin, leading to augmentation of iron concentra-
tions in infected macrophages favoring Mycobacterium growth.
As previously mentioned, intracellular iron accumulation could
also downregulate M1 phenotype by negatively affecting iNOS
expression (81).
Brucella spp. are facultative intracellular α-proteobacteria and
the causative agent of the world’s leading zoonotic disease bru-
cellosis (82). Its pathogenesis is mainly based on its ability to
survive and multiply inside macrophages. Treating Brucella abor-
tus-infected mice with a PPARγ inhibitor led to a significant
decrease in splenic colonization during the chronic phase of infec-
tion (83). In contrast, treatment of B. abortus-infected mice with
PPARγ agonist led to increased expression of M2 markers in
splenic macrophages and enhanced bacterial count in the spleen
during the chronic infection phase (83). These results strongly
suggest that pathways downstream of PPARγ contribute to gener-
ate a niche for persistence of B. abortus. In the same study (83),
further analysis of in vitro infected macrophages suggested that
PPARγ favors intracellular glucose availability for Brucella by shift-
ing the energetic cell metabolism from a typical M1-associated
glycolytic pathway to a glucose-sparing lipid oxidation associated
to M2 differentiation.
Although iron is needed by bacteria for growth, it also
plays an important role in the anti-microbial M1 activities of
macrophages such as generation of hydroxyl radicals. Brucella
appears well equipped to deal with the iron-poor environment
in M1 macrophages. Brucella expresses two siderophores [2,3-
dihydroxybenzoic acid (2,3-DHBA) and 2,3-DHBA-based mol-
ecule brucebactin] and a heme oxygenase (BhuO) allowing the
use of heme as an iron source [reviewed in Ref. (84)]. It has
been observed that iron supplementation increased the ability
of macrophages to control intracellular Brucella (85) suggesting
that iron chelation may represent a valuable strategy whereby this
bacterium impedes the generation of toxic hydroxyl radicals.
Salmonella are Gram-negative bacteria infecting hosts via the
gastrointestinal tract. Host-adapted strains of Salmonella enter-
ica cause systemic infections (typhoid fever) and have the ability
to asymptomatically persist within host tissues for long periods
of time in 1–6% of patients [reviewed in Ref. (86)]. Early pro-
tective Th1 responses are followed by pathogen-permissive Th2
responses. Salmonella infection caused accumulation and per-
sistence of hemophagocyte macrophages (characterized by the
ingestion of non-apoptotic cells) expressing M2 markers (CD36
and CD206) in spleen (87). During later stages of infection in vivo,
Salmonella was found preferentially associated with these cells
(88), possibly representing a specific niche for persistent infection.
PPARδwas found upregulated in Salmonella infected macrophages
in vitro. PPARδ deficiency dramatically inhibited Salmonella repli-
cation in vitro and in vivo and its pharmacological activation
enhanced bacterial growth in mice. Absence of PPARδ was associ-
ated to a decrease of available glucose necessary to Salmonella per-
sistence in macrophages (88). How macrophages acquire and/or
maintain an M2 phenotype in vivo during Salmonella infection is
presently unknown.
Leishmania represent obligate intracellular protozoan parasites
that are transmitted in the dermis of the mammalian host by
blood-feeding sand flies. After transmission, these parasites invade
mainly macrophages, which are decisive effector cells that either
kill or host the intracellular parasites depending on the balance
of iNOS and Arg1 [reviewed in Ref. (89)]. Control of parasite
growth was associated with the induction of strong Th1 responses
and induction of iNOS-expressing M1 macrophage. Accordingly,
there was a clear direct correlation between the parasite load and
the arginase activity in the lesions. Inhibition of arginase activ-
ity during the course of infection reduced parasite growth (43).
In vitro, parasitized dendritic cells showed coordinated transcrip-
tional modulations that correlated in part to PPARχ upregulation
and promoted the generation and storage of neutral lipids, such as
triacyl-sn-glycerol and cholesteryl esters (90), that can be impor-
tant for the synthesis of key parasite membrane components.
Accumulation of neutral lipid has been also shown to reduce anti-
gen processing and presentation to effector T cells (91). Leishmania
parasites are coated with phosphatidylserine (92), a major surface
characteristic of apoptotic cells (93) recognized by CD36 expressed
by M2 macrophages (94). As engulfment of apoptotic cells by
CD36 pathways leads to induction of PPAR, it is possible that
Leishmania actively promotes M2 polarization of macrophages
as a virulence strategy. Of note, a recent report shows that the
macrophage response upon visceral infection with Leishmania
infantum is characterized by an M2b-like phenotype, identified
by expression of C-type lectin receptors signature (95).
Francisella tularensis, a gram-negative intracellular bacteria and
the causative agent of tularemia, induces acute and frequently
lethal pulmonary infection. F. tularensis replicates in myeloid cells
and alveolar epithelial cells in lung of infected mice [reviewed
in (96)]. It has been observed that virulent strains induce M2
activation markers on macrophages in wild type but not in IL-
4Rα or STAT6 deficient mice (97). Lipid isolated from virulent
strain but not from attenuated strain appeared able to induce a
TLR2/PPARγ-dependent M2 polarization of macrophage (98),
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suggesting that redirection of macrophage polarization by F.
tularensis could constitute an escape immune mechanism.
Listeria monocytogenes is a facultative intracellular Gram-
positive bacteria able of serious acute infection. Listeria infection
of macrophages rapidly led to increased expression of PPARγ
(99). Selective loss of PPARγ in myeloid cells resulted in enhanced
innate immune defense against Listeria both, in vitro and in vivo
suggesting that PPARγ-dependent M2 phenotype could favor L.
monocytogenes multiplication.
T. gondii represents one of clear examples of how an intracel-
lular parasite can subvert macrophage polarization to enhance its
infectivity. This parasite secretes into the cytoplasm of infected
macrophage several virulence factors including a protein, ROP16,
displaying protein kinase activity. Remarkably, this protein inter-
feres with the host signaling machinery through the direct phos-
phorylation of STAT6 (and STAT3), bypassing therefore early
cytokine receptor proximal events. Notably, ROP16 was shown
to phosphorylate STAT6 on the critical activation residue Tyr641
(39), resulting in the productive transcription of M2-associated
genes including Arg1 (41, 100).
In conclusion, numerous evidences suggest that some intra-
cellular bacterial and protozoan pathogens responsible for
chronic (Mycobacteria, Brucella, Leishmania, and Toxoplasma) but
also acute (Francisella and Listeria) infection actively manip-
ulate STAT6-PPARγ/δ pathways to avoid M1 polarization of
macrophages and/or benefit from a nutrient rich environment
associated to lipid oxidation metabolism. Although the possi-
ble impact of macrophage polarization on chronic viral infec-
tions remains largely unknown, recent studies suggest that HBV-
induced M2 macrophage polarization can participate to immune
impairment and pathology (101). Thus, PPARγ/δ pathways hold
a pivotal role in the establishment of chronic infection and their
ligands may be used as combination therapeutics to limit host
pathology or pathogen persistence.
BENEFICIAL ROLE OF Th2 RESPONSE AND ALTERNATIVELY
ACTIVATED MACROPHAGE DURING INFECTION
It is well appreciated that M2 macrophages can act to limit dis-
ease severity and protect the host from detrimental effects of
an excessive Th1 response, making symbiotic survival between
host and parasites more likely. For example, infection of mice or
humans with the trematode S. mansoni results in a Th2 dependent
response. Neutralization of IL-4 or genetic invalidation of IL-4/IL-
13 led to increased rates of mortality during acute schistosomiasis,
illustrating the protective role of Th2 in this experimental model.
Mice rendered selectively deficient for IL-4R in macrophages were
extremely susceptible to infection with 100% mortality, suggest-
ing that M2 macrophages are essential during schistosomiasis for
protection against organ injury.
In addition, M2 macrophages can also display anti-microbial
effector function and actively reduce the level of infection by
various pathogens.
Infective larvae of the nematode N. brasiliensis enter host ani-
mals through skin penetration and further migrate in the lungs
and intestine. Primary protective response against N. brasiliensis
relied mostly on an IL-13-dependent goblet cell hyperplasia lead-
ing to increased mucus production in the intestine. Accordingly,
IL-4Rα and STAT6 deficient mice failed to expulse the gastroin-
testinal nematode parasite (102). Interestingly, protective memory
response against N. brasiliensis implicated neutralization of larva
migration from skin to lung (48). Larval trapping was dependent
on induction of M2 macrophage differentiation from recruited
monocytes as demonstrated by the fact that neutralization of IL-4
or Arg1 abolished larval trapping.
The central pathophysiologic events in severe malaria caused
by Plasmodium falciparum are the inability of the host defenses to
control parasite replication resulting in the excessive release of pro-
inflammatory cytokines. Mice treated with an agonist of PPARγ
had reduced parasitemia of Plasmodium and decreased inflam-
matory response (103). This effect was mediated by CD36 that
served as ligand for P. falciparum erythrocyte membrane protein 1
(PfEMP-1) expressed by the parasite (104). CD36-mediated inter-
nalization by M2 macrophages facilitated removal of neutrophils
and dead tissues to resolve inflammation as well as clearing of the
parasite. P. falciparum used host hemoglobin as iron source and
sequestered heme into a pigment known as hemozoin. It has been
showed that hemozoin reacted with membrane phospholipids to
generate hydroxy-polyunsaturated fatty acids which are ligands of
PPARγ (105), suggesting that the parasite can actively modulate
its growth by a PPARγ pathway.
The cestode Mesocestoides corti induces a central nervous sys-
tem infection in mice dominated by M2 macrophages. Absence
of STAT6 signaling resulted in enhanced susceptibility to infec-
tion coinciding with increased parasite burden in the brain (106)
suggesting that M2 macrophages actively control infection.
The ubiquitous fungus Aspergillus fumigatus causes invasive
and allergenic disease. Host defense relied on the ability of the res-
piratory immune system to restrict spore germination into invasive
hyphae and to limit fungus-induced or inflammation-induced
damage in infected tissues. Infection induced a M2 polarization of
alveolar macrophages. Control of infection appeared dependent
on dectin-1 mediated phagocytosis of fungus by M2 macrophages
(107) as dectin-1 deficiency or elimination of M2 macrophages
was associated to increased fungal burden in mice.
PLASTICITY OF MACROPHAGE POLARIZATION DURING
INFECTION: TWO OPPOSITE EXAMPLES
Several infectious experimental models demonstrate that immune
polarization may display high plasticity, suggesting that M1
and M2 phenotypes may not represent terminally differentiated
cells.
Classically, M1 macrophages are implicated in initiating and
sustaining inflammation, whereas M2 macrophages differenti-
ate later and are involved in resolution of inflammation and
tissue regeneration. In particular, the early and late phases of
Trypanosoma congolense infection are characterized by M1 and
M2 polarization of macrophages, respectively. The shift to M2
appears indispensable to control inflammation and limit tissue
injury (105).
However, the opposite scenario has also been reported. Cryp-
tococcus neoformans, the etiological agent of cryptococcosis con-
stitutes a well-documented case of M2-to-M1 shift in vivo. After
inhalation, C. neoformans resides primarily in the alveolar spaces,
where it can survive and replicate in the extracellular lung
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environment. The immune response in C. neoformans-infected
C57BL/6 wild type mice is predominantly Th2 biased and asso-
ciated with development of M2 macrophages. These latter serve
as intracellular reservoirs for the microbe and promote the devel-
opment of lung pathology (108). In this model, neutralization
of IFN-γ resulted in more severe pulmonary infections and
lesions (109). In contrast, IL-4 (109) or IL-13 (110) deletion
led to Th1-dominated immune responses associated with M1
macrophage granuloma formation displaying iNOS dependent
fungicidal activity. Interestingly, the lung immune polarization
environment changed overtime (108). Following a strong initial
induction of Th2 cytokines in the lungs at 2 and 3 weeks post-
infection, a considerable increase in Th1 cytokines occurred at
5 weeks post-infection. This increase in Th1 cytokines was accom-
panied by a decrease in Th2 cytokines, indicating that the immune
system is spontaneously capable of a Th2–Th1 shift. However,
if it is now appreciated that polarized T cells exhibit previously
unsuspected flexibility and plasticity (111), it remains unclear
whether macrophage polarization switches involve recruitment of
new precursors or de-differentiation of macrophages in situ.
Collectively, these observations suggest that macrophages can
undergo dynamic transitions between different functional states.
This polarization switch may provide protection to uncontrolled
inflammation or constitute an indispensable adaptation to rapid
phenotypic change of pathogen during its cycle.
CONCLUSIONS
In summary, the available evidences are compatible with the origi-
nal view of a“division of labor”between M1 and M2 macrophages.
M1 macrophages do display an increased microbicidal activity
against a wide range of intracellular parasites, while differentiation
toward an M2-like state is often observed during the resolution
phase of an inflammatory response, favoring in particular tissue
repair. This purely dualistic view needs, however, to be considered
with care, since M1 macrophages are also able to negatively control
an inflammatory response (through notably NO production and
IDO1-mediated tryptophan catabolism), while M2 macrophages
display anti-microbial activities via expression of Arg1 (Figure 4).
The M1/M2 cell paradigm represents, therefore, an additional
example of pathogen-tailored immune effectors, endowed with
regulatory properties.
A growing number of clinically relevant infectious diseases are
characterized by pathogen persistence in the host. Chronic and
recurrent infections implicate long-lasting and costly therapy and
are the cause of an important morbidity in the world. Therefore,
there is a strong interest in understanding the biology of pathogen
persistence.
Numerous reports demonstrate that chronic bacterial persis-
tence in vivo depends on the ability of bacteria to resist the
anti-microbial activity but also to reconfigure local host envi-
ronment to their profit (112). Pathogens exploit host regulatory
pathways limiting damaging inflammatory responses for the ben-
efit of tolerance. They also reprogram host cell metabolism to
produce nutrients necessary for their long-term persistence (88,
113). Similar results have been obtained in parasitic infections (12,
89) suggesting that induction of a metabolic shift in infected cells
constitutes a general strategy to favor persistence. In this paradigm,
FIGURE 4 | Multipolar view of M1 and M2a polarization.
PPARs family seems key actor in the hijacking of macrophages by
pathogens and an interesting target for therapeutic strategy.
Targeting microbial nutrient requirements represents a promis-
ing therapeutic strategy. Both anti-microbial compounds and vac-
cine have been created to specifically target pathogen iron acquisi-
tion systems [reviewed in Ref. (65)]. Unfortunately, microbes often
possess redundant mechanisms for nutrient acquisition. A better
understanding of these mechanisms may lead to the development
of new strategies to control infection.
The importance of nutrient availability in control of infection
also leads to focus our attention on the multifactorial and complex
impact of modern fat rich diet on chronic infection. Commensal
and mutualistic microorganisms are present in all mucosal com-
partments and form the microbiota. These symbiotic organisms
compete with pathogenic microorganisms for nutrients, thereby
preventing pathogenic colonization and invasion. As discussed
above, obesity can affect macrophage polarization but also dras-
tically change the composition of host microbial community and
thus its ability to compete with pathogen for host nutriment avail-
ability. A better knowledge of the relationship between nutrition,
microbiota, and immune defense could provide guidelines for
prophylactic nutritional measures to protect against and/or treat
infections.
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